Login
Register
Submit a Paper
Propose a Special lssue
Open Access
REVIEW
State of the art review: Chemotherapy-induced cardiotoxicity in children
Pediatric Cardiology, Texas Children’s Hospital/Baylor College of Medicine, Houston, Texas, USA
* Corresponding Author: Robert W. Loar, MD, Texas Children’s Hospital/Baylor College of Medicine, 6621 Fannin Street, MC 19345-C, Houston, TX 77030, USA. Email:
Congenital Heart Disease 2018, 13(1), 5-15. https://doi.org/10.1111/chd.12564
Download PDFAbstract
Chemotherapy-induced cardiotoxicity in adults and children is a topic with a growing interest in the cardiology literature. The ability to detect cardiac dysfunction in a timely manner is essential in order to begin adequate treatment and prevent further deterioration. This article aims to provide a review on the myocardial injury process, chemotherapeutic agents that lead to cardiotoxicity, the definition of cardiotoxicity, and the methods of timely detection and treatment.Keywords
Cite This Article
APA Style
Loar, R.W., Noel, C.V., Tunuguntla, H., Colquitt, J.L., Pignatelli, R.H. (2018). State of the art review: chemotherapy-induced cardiotoxicity in children. Congenital Heart Disease, 13(1), 5-15. https://doi.org/10.1111/chd.12564
Vancouver Style
Loar RW, Noel CV, Tunuguntla H, Colquitt JL, Pignatelli RH. State of the art review: chemotherapy-induced cardiotoxicity in children. Congeni Heart Dis. 2018;13(1):5-15 https://doi.org/10.1111/chd.12564
IEEE Style
R.W. Loar, C.V. Noel, H. Tunuguntla, J.L. Colquitt, and R.H. Pignatelli, “State of the art review: Chemotherapy-induced cardiotoxicity in children,” Congeni. Heart Dis., vol. 13, no. 1, pp. 5-15, 2018. https://doi.org/10.1111/chd.12564
Copyright © 2018 The Author(s). Published by Tech Science Press.This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Downloads
Citation Tools
